» Articles » PMID: 29441757

Changing Epidemiology of Nontuberculous Mycobacterial Lung Diseases in a Tertiary Referral Hospital in Korea Between 2001 and 2015

Overview
Specialty General Medicine
Date 2018 Feb 15
PMID 29441757
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated the changes in the major etiologic organisms and clinical phenotypes of nontuberculous mycobacterial lung disease (NTM-LD) over a recent 15-year period in Korea. The increase of number of patients with NTM-LD was primarily due to an increase of Mycobacterium avium complex (MAC) lung disease (LD). Among MAC cases, the proportion of M. avium increased compared with M. intracellulare, whereas the incidence of M. abscessus complex and M. kansasii LD remained relatively stable. The proportion of cases of the nodular bronchiectatic form increased compared with the fibrocavitary form of NTM-LD.

Citing Articles

Exploring the Association of Bacterial Coinfections with Clinical Characteristics of Patients with Nontuberculous Mycobacterial Pulmonary Disease.

Moon S, Cho H, Shin B Tuberc Respir Dis (Seoul). 2024; 87(4):505-513.

PMID: 39362831 PMC: 11468447. DOI: 10.4046/trd.2024.0003.


Change of erythrocyte sedimentation rate as prognostic biomarker for complex pulmonary disease through anti-mycobacterial treatment.

Hwang H, Kim J, Yim J, Kwak N Ther Adv Respir Dis. 2024; 18:17534666241282272.

PMID: 39311055 PMC: 11421399. DOI: 10.1177/17534666241282272.


Nontuberculous mycobacterial infection in Wisconsin children and adolescents.

Vonasek B, Gusland D, Tans-Kersten J, Misch E, Gibbons-Burgener S J Clin Tuberc Other Mycobact Dis. 2024; 36:100456.

PMID: 38974997 PMC: 11227012. DOI: 10.1016/j.jctube.2024.100456.


Treatment Outcomes of Clofazimine-Containing Regimens in Severe Complex Pulmonary Disease.

Lee I, Hwang E, Kim J, Yim J, Kwak N Open Forum Infect Dis. 2024; 11(2):ofad682.

PMID: 38328494 PMC: 10849115. DOI: 10.1093/ofid/ofad682.


Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review.

Prevots D, Marshall J, Wagner D, Morimoto K Clin Chest Med. 2023; 44(4):675-721.

PMID: 37890910 PMC: 10625169. DOI: 10.1016/j.ccm.2023.08.012.


References
1.
Kim N, Yi J, Chang C . Recovery Rates of Non-Tuberculous Mycobacteria from Clinical Specimens Are Increasing in Korean Tertiary-Care Hospitals. J Korean Med Sci. 2017; 32(8):1263-1267. PMC: 5494324. DOI: 10.3346/jkms.2017.32.8.1263. View

2.
Park Y, Lee C, Lee S, Yang S, Yoo C, Kim Y . Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis. 2010; 14(8):1069-71. View

3.
Koh W, Moon S, Kim S, Woo M, Kim S, Jhun B . Outcomes of complex lung disease based on clinical phenotype. Eur Respir J. 2017; 50(3). DOI: 10.1183/13993003.02503-2016. View

4.
Koh W, Jeon K, Lee N, Kim B, Kook Y, Lee S . Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med. 2010; 183(3):405-10. DOI: 10.1164/rccm.201003-0395OC. View

5.
Stout J, Koh W, Yew W . Update on pulmonary disease due to non-tuberculous mycobacteria. Int J Infect Dis. 2016; 45:123-34. DOI: 10.1016/j.ijid.2016.03.006. View